STRAUMANN HOLDING AG-REG (QS51.DE) Stock Fundamental Analysis
Europe - FRA:QS51 - CH1175448666 - Common Stock
98 EUR
+1.02 (+1.05%)
QS51 gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 58 industry peers in the Health Care Equipment & Supplies industry. QS51 has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, QS51 is valued expensive at the moment. With these ratings, QS51 could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
QS51 had positive earnings in the past year.
In the past year QS51 had a positive cash flow from operations.
Each year in the past 5 years QS51 has been profitable.
In the past 5 years QS51 always reported a positive cash flow from operatings.
1.2 Ratios
QS51 has a Return On Assets of 11.23%. This is amongst the best in the industry. QS51 outperforms 87.93% of its industry peers.
With an excellent Return On Equity value of 19.18%, QS51 belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
With an excellent Return On Invested Capital value of 20.46%, QS51 belongs to the best of the industry, outperforming 98.28% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for QS51 is significantly above the industry average of 8.65%.
The 3 year average ROIC (19.58%) for QS51 is below the current ROIC(20.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.23% | ||
| ROE | 19.18% | ||
| ROIC | 20.46% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
1.3 Margins
Looking at the Profit Margin, with a value of 15.29%, QS51 belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
In the last couple of years the Profit Margin of QS51 has declined.
With an excellent Operating Margin value of 25.33%, QS51 belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
QS51's Operating Margin has been stable in the last couple of years.
QS51 has a better Gross Margin (71.24%) than 81.03% of its industry peers.
QS51's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.33% | ||
| PM (TTM) | 15.29% | ||
| GM | 71.24% |
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), QS51 is creating value.
The number of shares outstanding for QS51 remains at a similar level compared to 1 year ago.
The number of shares outstanding for QS51 has been increased compared to 5 years ago.
QS51 has a better debt/assets ratio than last year.
2.2 Solvency
QS51 has an Altman-Z score of 8.59. This indicates that QS51 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.59, QS51 belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
The Debt to FCF ratio of QS51 is 1.43, which is an excellent value as it means it would take QS51, only 1.43 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.43, QS51 belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
QS51 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
QS51 has a Debt to Equity ratio of 0.10. This is in the better half of the industry: QS51 outperforms 79.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.43 | ||
| Altman-Z | 8.59 |
ROIC/WACC4.12
WACC4.97%
2.3 Liquidity
A Current Ratio of 1.64 indicates that QS51 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.64, QS51 perfoms like the industry average, outperforming 46.55% of the companies in the same industry.
QS51 has a Quick Ratio of 1.13. This is a normal value and indicates that QS51 is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.13, QS51 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
QS51 does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The earnings per share for QS51 have decreased strongly by -14.56% in the last year.
QS51 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.26% yearly.
QS51 shows a small growth in Revenue. In the last year, the Revenue has grown by 7.18%.
The Revenue has been growing by 9.42% on average over the past years. This is quite good.
EPS 1Y (TTM)-14.56%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-5.68%
Revenue 1Y (TTM)7.18%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%5.89%
3.2 Future
QS51 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.07% yearly.
QS51 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.41% yearly.
EPS Next Y19.24%
EPS Next 2Y17.6%
EPS Next 3Y16.94%
EPS Next 5Y17.07%
Revenue Next Year6.16%
Revenue Next 2Y7.73%
Revenue Next 3Y8.31%
Revenue Next 5Y9.41%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 34.63, the valuation of QS51 can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of QS51 is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.06, QS51 is valued a bit more expensive.
A Price/Forward Earnings ratio of 24.14 indicates a rather expensive valuation of QS51.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QS51 is on the same level as its industry peers.
QS51 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.63 | ||
| Fwd PE | 24.14 |
4.2 Price Multiples
QS51's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as QS51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.08 | ||
| EV/EBITDA | 17.91 |
4.3 Compensation for Growth
QS51's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of QS51 may justify a higher PE ratio.
A more expensive valuation may be justified as QS51's earnings are expected to grow with 16.94% in the coming years.
PEG (NY)1.8
PEG (5Y)6.58
EPS Next 2Y17.6%
EPS Next 3Y16.94%
5. Dividend
5.1 Amount
QS51 has a Yearly Dividend Yield of 1.04%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.14, QS51 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, QS51's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
5.2 History
On average, the dividend of QS51 grows each year by 10.12%, which is quite nice.
Dividend Growth(5Y)10.12%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.37% of the earnings are spent on dividend by QS51. This is a low number and sustainable payout ratio.
The dividend of QS51 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP38.37%
EPS Next 2Y17.6%
EPS Next 3Y16.94%
FRA:QS51 (9/25/2025, 7:00:00 PM)
98
+1.02 (+1.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners38.22%
Inst Owner ChangeN/A
Ins Owners32.32%
Ins Owner ChangeN/A
Market Cap15.63B
Analysts73.33
Price Target131.12 (33.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
Yearly Dividend0.91
Dividend Growth(5Y)10.12%
DP38.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.64%
PT rev (3m)-7.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-2.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.63 | ||
| Fwd PE | 24.14 | ||
| P/S | 5.66 | ||
| P/FCF | 48.08 | ||
| P/OCF | 29.17 | ||
| P/B | 7.09 | ||
| P/tB | 12.21 | ||
| EV/EBITDA | 17.91 |
EPS(TTM)2.83
EY2.89%
EPS(NY)4.06
Fwd EY4.14%
FCF(TTM)2.04
FCFY2.08%
OCF(TTM)3.36
OCFY3.43%
SpS17.32
BVpS13.82
TBVpS8.03
PEG (NY)1.8
PEG (5Y)6.58
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.23% | ||
| ROE | 19.18% | ||
| ROCE | 24.94% | ||
| ROIC | 20.46% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 37.67% | ||
| OM | 25.33% | ||
| PM (TTM) | 15.29% | ||
| GM | 71.24% | ||
| FCFM | 11.77% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
ROICexc(3y)24.47%
ROICexc(5y)23.84%
ROICexgc(3y)42.44%
ROICexgc(5y)41.27%
ROCE(3y)23.86%
ROCE(5y)21.7%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-1.8%
ROICexc growth 3Y-7.31%
ROICexc growth 5Y1.25%
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
F-Score7
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.43 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 128.05% | ||
| Cap/Sales | 7.63% | ||
| Interest Coverage | 44.11 | ||
| Cash Conversion | 61.99% | ||
| Profit Quality | 76.93% | ||
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 8.59 |
F-Score7
WACC4.97%
ROIC/WACC4.12
Cap/Depr(3y)127.11%
Cap/Depr(5y)116.21%
Cap/Sales(3y)7.81%
Cap/Sales(5y)7.04%
Profit Quality(3y)86.54%
Profit Quality(5y)138.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.56%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-5.68%
EPS Next Y19.24%
EPS Next 2Y17.6%
EPS Next 3Y16.94%
EPS Next 5Y17.07%
Revenue 1Y (TTM)7.18%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%5.89%
Revenue Next Year6.16%
Revenue Next 2Y7.73%
Revenue Next 3Y8.31%
Revenue Next 5Y9.41%
EBIT growth 1Y0.07%
EBIT growth 3Y6.31%
EBIT growth 5Y9.56%
EBIT Next Year31.64%
EBIT Next 3Y18.52%
EBIT Next 5Y16.07%
FCF growth 1Y20.16%
FCF growth 3Y-10.44%
FCF growth 5Y6.66%
OCF growth 1Y12.05%
OCF growth 3Y-4.8%
OCF growth 5Y5.01%